Adverse event terms from the Common Toxicity Criteria for Adverse Events version 4.02 were used for adverse event grading for this trial, and these terms are used in this table; all greater than grade 1 adverse events are listed regardless of attribution. ALT, alanine amino transferase; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase.

All patients had grade 4 lymphocyte count decreased, which was expected after the chemotherapy conditioning regimen that the patients received. Lymphocyte count decreased was not listed repetitively for each patient.

Creatine phosphokinase elevation in this patient was almost certainly caused by exercise.